| Rodrigo Santos |
Rodrigo Santos is currently the President-Crop Science Division at Bayer AG and a Member at Greater St Louis, Inc. He holds an MBA from The Ohio University and an undergraduate degree from Escola Superior de Agricultura Luiz de Queiroz. |
| Norbert Winkeljohann |
Norbert Winkeljohann currently works at Deutsche Bank AG, as Deputy Chairman-Supervisory Board from 2022, Bayer AG, as Chairman-Supervisory Board from 2020, Sievert SE, as Chairman-Supervisory Board, Bohnenkamp AG, as Chairman-Supervisory Board, and Georgsmarienhütte Holding GmbH, as Member-Supervisory Board. Dr. Winkeljohann also formerly worked at heristo AG, as Co-Chairman-Supervisory Board from 2018 to 2021, PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft, as Chairman-Management Board from 2010 to 2018, Pwc Europe SE Wirtschaftspruefungsgesellschaft, as Chairman-Management Board from 2011 to 2018, Sievert Baustoffe GmbH & Co. KG, as Managing Director, PricewaterhouseCoopers AG Wirtschaftsprüfungsgesellschaft, as Head-Mid-Caps & Family Firms Business Division from 1999 to 2010, Societâts Treuhand GmbH, as Auditor & Executive Partner from 1994 to 1998, and PricewaterhouseCoopers International Ltd., as Member-Network Leadership Team from 2010 to 2018. Dr. Winkeljohann received his Masters Business Admin degree in 1983 from the University of Münster and doctorate degree in 1986 from the University of Hagen. |
| Bijoy Sagar |
Bijoy Sagar is currently the Director at AI Lean, Inc. and the Chief Information Technology Officer at Bayer AG. Previously, he held positions as the Chief Digital Technology Officer & Vice President at Stryker Corp., the Global Head-Information Systems at Merck KGaA, and the Chief Information Officer at Merck Millipore Corp. He received his undergraduate and graduate degrees from the University of Mumbai. |
| Wolfgang U. Nickl |
Wolfgang U. Nickl is currently the Head-Finance at Bayer AG since 2018. Prior to his current position, he served as the Chief Financial Officer & Executive Vice President at ASML Holding NV from 2013 to 2018 and at Western Digital Corp. from 2012 to 2013. He also held the position of Chief Financial Officer at PCG Trading LLC. Mr. Nickl obtained an MBA from USC Marshall School of Business in 2005 and an undergraduate degree from Duale Hochschule Baden-Württemberg Villingen-Schwenningen in 1992. |
| William N. Anderson |
William N. Anderson is currently the Chief Executive Officer at Bayer AG since 2023. He is also serving as the Director at Chugai Pharmaceutical Co., Ltd. since 2019 and as a Director at Pharmaceutical Research & Manufacturers of America. Previously, he held the position of Chief Executive Officer & Director at Genentech, Inc. He was also the Chief Executive Officer at Roche Pharmaceuticals, Inc. from 2019 to 2022 and at Roche Pharma (Schweiz) AG from 2019 to 2023. Prior to that, he worked as the Vice President-Neurology Unit at Biogen, Inc. from 2004 to 2006. Mr. Anderson completed his graduate degree from Massachusetts Institute of Technology and his undergraduate degree from The University of Texas at Austin. |
| Christian Rommel |
Christian Rommel currently works at AskBio Inc., as Director, Vividion Therapeutics, Inc., as Director, CRISPR Therapeutics AG, as Independent Director from 2024, and Bayer AG, as EVP, Head-Research & Development. Dr. Rommel also formerly worked at Regeneron Pharmaceuticals, Inc., as Senior Scientist, Intellikine LLC, as Chief Scientific Officer from 2007 to 2012, Merck Serono Ltd., as Head-Target Research, Amgen, Inc., as VP-External Research & Development, and F. Hoffmann-La Roche Ltd., as SVP, Head-Oncology Research & Early Development from 2018 to 2021. Dr. Rommel received his doctorate degree from Max-Planck-Institute for Molecular Genetics and undergraduate degree from the University of Greifswald. |
| Philipp Blank |
Philipp Blank currently works at Bayer AG, as Head-Law, Compliance & Information Technology. |
| Stefan Oelrich |
Stefan Oelrich is currently the Director at Vividion Therapeutics, Inc. He is also the President-Pharmaceuticals Division at Bayer AG and a Member of the Management Board at the American Chamber of Commerce in Germany eV. Additionally, he serves as an Advisor at Longwood Fund Management LLC and is a Member of the Supervisory Board at the Berlin Institute of Health and Charité - Universitätsmedizin Berlin. Formerly, Mr. Oelrich worked at Sanofi as the Executive VP-Diabetes & Cardiovascular from 2011 to 2018. He also held a position as Senior Vice President & General Manager at Women's Healthcare. |
| Julio Triana |
Julio Triana is currently the President at Bayer Holding Ltd. He is also the President-Consumer Health Division at Bayer AG since 2002 and the Head-Commercial Operations Region at Bayer Pharmaceuticals since 2016. Previously, he worked as the Chief Transformation Officer at Bayer Yakuhin Ltd. Mr. Triana completed his undergraduate degree at the University of Houston and holds an MBA from Nebrija University. |
